vs
STANDARD BIOTOOLS INC.（LAB）与SIFCO INDUSTRIES INC（SIF）财务数据对比。点击上方公司名可切换其他公司
SIFCO INDUSTRIES INC的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$24.0M vs $19.6M），SIFCO INDUSTRIES INC净利率更高（7.5% vs -177.4%，领先184.9%），SIFCO INDUSTRIES INC同比增速更快（14.8% vs -11.5%），SIFCO INDUSTRIES INC自由现金流更多（$8.0M vs $-23.1M），过去两年SIFCO INDUSTRIES INC的营收复合增速更高（8.1% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
锡福科工业公司（SIFCO INDUSTRIES INC）是一家总部位于俄亥俄州克利夫兰的全球性金属零部件制造企业，在行业内面向全球市场供应各类所需金属构件产品。
LAB vs SIF — 直观对比
营收规模更大
SIF
是对方的1.2倍
$19.6M
营收增速更快
SIF
高出26.3%
-11.5%
净利率更高
SIF
高出184.9%
-177.4%
自由现金流更多
SIF
多$31.1M
$-23.1M
两年增速更快
SIF
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $24.0M |
| 净利润 | $-34.7M | $1.8M |
| 毛利率 | 48.5% | 21.6% |
| 营业利润率 | -168.5% | 10.7% |
| 净利率 | -177.4% | 7.5% |
| 营收同比 | -11.5% | 14.8% |
| 净利润同比 | -28.8% | 177.3% |
| 每股收益（稀释后） | $-0.09 | $0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABSIF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $19.6M | $22.8M | ||
| Q2 25 | $21.8M | $22.1M | ||
| Q1 25 | $40.8M | $19.0M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | $22.1M | $21.7M | ||
| Q2 24 | $22.5M | $22.0M | ||
| Q1 24 | $45.5M | $20.5M |
净利润LABSIF
| Q4 25 | — | $1.8M | ||
| Q3 25 | $-34.7M | $-429.0K | ||
| Q2 25 | $-33.5M | $3.4M | ||
| Q1 25 | $-26.0M | $-1.4M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | $-26.9M | $-443.0K | ||
| Q2 24 | $-45.7M | $72.0K | ||
| Q1 24 | $-32.2M | $-1.6M |
毛利率LABSIF
| Q4 25 | — | 21.6% | ||
| Q3 25 | 48.5% | 9.6% | ||
| Q2 25 | 48.8% | 26.7% | ||
| Q1 25 | 48.4% | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | 54.9% | 10.7% | ||
| Q2 24 | 46.1% | 12.3% | ||
| Q1 24 | 53.1% | 7.3% |
营业利润率LABSIF
| Q4 25 | — | 10.7% | ||
| Q3 25 | -168.5% | -1.7% | ||
| Q2 25 | -118.1% | 14.8% | ||
| Q1 25 | -80.8% | -4.1% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | -120.9% | -1.5% | ||
| Q2 24 | -134.5% | 0.7% | ||
| Q1 24 | -132.2% | -6.5% |
净利率LABSIF
| Q4 25 | — | 7.5% | ||
| Q3 25 | -177.4% | -1.9% | ||
| Q2 25 | -153.7% | 15.4% | ||
| Q1 25 | -63.8% | -7.3% | ||
| Q4 24 | — | -11.1% | ||
| Q3 24 | -122.0% | -2.0% | ||
| Q2 24 | -203.3% | 0.3% | ||
| Q1 24 | -70.6% | -7.8% |
每股收益（稀释后）LABSIF
| Q4 25 | — | $0.29 | ||
| Q3 25 | $-0.09 | $-0.07 | ||
| Q2 25 | $-0.09 | $0.56 | ||
| Q1 25 | $-0.07 | $-0.23 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | $-0.07 | $-0.07 | ||
| Q2 24 | $-0.12 | $0.01 | ||
| Q1 24 | $-0.27 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $1.1M |
| 总债务越低越好 | — | $39.0K |
| 股东权益账面价值 | $399.7M | $38.7M |
| 总资产 | $539.6M | $74.9M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资LABSIF
| Q4 25 | — | $1.1M | ||
| Q3 25 | $129.4M | $491.0K | ||
| Q2 25 | $158.6M | $2.0M | ||
| Q1 25 | $150.9M | $1.9M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $210.6M | $1.7M | ||
| Q2 24 | $269.8M | $3.4M | ||
| Q1 24 | $287.1M | $2.5M |
总债务LABSIF
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | $0 | ||
| Q2 24 | $55.1M | $3.6M | ||
| Q1 24 | $55.0M | $4.1M |
股东权益LABSIF
| Q4 25 | — | $38.7M | ||
| Q3 25 | $399.7M | $36.9M | ||
| Q2 25 | $424.5M | $35.8M | ||
| Q1 25 | $454.6M | $32.4M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | $489.3M | $30.4M | ||
| Q2 24 | $510.3M | $29.8M | ||
| Q1 24 | $577.3M | $29.7M |
总资产LABSIF
| Q4 25 | — | $74.9M | ||
| Q3 25 | $539.6M | $73.4M | ||
| Q2 25 | $557.0M | $77.3M | ||
| Q1 25 | $579.6M | $78.8M | ||
| Q4 24 | — | $81.0M | ||
| Q3 24 | $681.5M | $104.6M | ||
| Q2 24 | $708.7M | $106.3M | ||
| Q1 24 | $777.7M | $104.2M |
负债/权益比LABSIF
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | 0.00× | ||
| Q2 24 | 0.11× | 0.12× | ||
| Q1 24 | 0.10× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $8.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $8.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 33.3% |
| 资本支出强度资本支出/营收 | 4.5% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 4.51× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $11.5M |
8季度趋势，按日历期对齐
经营现金流LABSIF
| Q4 25 | — | $8.1M | ||
| Q3 25 | $-22.2M | $726.0K | ||
| Q2 25 | $-20.7M | $371.0K | ||
| Q1 25 | $-30.3M | $2.8M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | $-27.9M | $857.0K | ||
| Q2 24 | $-39.0M | $382.0K | ||
| Q1 24 | $-62.5M | $-3.2M |
自由现金流LABSIF
| Q4 25 | — | $8.0M | ||
| Q3 25 | $-23.1M | $566.0K | ||
| Q2 25 | $-22.6M | $310.0K | ||
| Q1 25 | $-35.3M | $2.7M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $-30.1M | $580.0K | ||
| Q2 24 | $-41.0M | $-175.0K | ||
| Q1 24 | $-63.3M | $-3.9M |
自由现金流率LABSIF
| Q4 25 | — | 33.3% | ||
| Q3 25 | -118.1% | 2.5% | ||
| Q2 25 | -103.6% | 1.4% | ||
| Q1 25 | -86.6% | 14.1% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | -136.4% | 2.7% | ||
| Q2 24 | -182.2% | -0.8% | ||
| Q1 24 | -138.9% | -18.9% |
资本支出强度LABSIF
| Q4 25 | — | 0.4% | ||
| Q3 25 | 4.5% | 0.7% | ||
| Q2 25 | 8.7% | 0.3% | ||
| Q1 25 | 12.4% | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | 10.2% | 1.3% | ||
| Q2 24 | 8.6% | 2.5% | ||
| Q1 24 | 1.7% | 3.3% |
现金转化率LABSIF
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
